Danaher Corporation $DHR Shares Purchased by Journey Advisory Group LLC

Journey Advisory Group LLC increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 869.6% in the second quarter, Holdings Channel reports. The firm owned 14,544 shares of the conglomerate’s stock after acquiring an additional 13,044 shares during the period. Journey Advisory Group LLC’s holdings in Danaher were worth $2,873,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 99 shares in the last quarter. Sierra Ocean LLC increased its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC increased its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares in the last quarter. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher during the 1st quarter worth approximately $31,000. Finally, Ramirez Asset Management Inc. acquired a new stake in Danaher during the 2nd quarter worth approximately $40,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.20% of the stock is owned by corporate insiders.

Danaher Stock Performance

Shares of DHR opened at $209.14 on Monday. The business’s fifty day moving average price is $201.60 and its 200 day moving average price is $197.24. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $275.51. The stock has a market capitalization of $149.76 billion, a PE ratio of 44.50, a price-to-earnings-growth ratio of 2.98 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period last year, the business posted $1.72 earnings per share. The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on DHR shares. Bank of America reduced their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research note on Monday, September 22nd. Guggenheim reiterated a “buy” rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. UBS Group reduced their target price on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $245.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.